About neuroone medical technologies corp - NMTC
NeuroOne Medical Technologies Corp. is a medical technology company, which engages in diagnostics, ablations, and deep brain stimulation technology for brain-related conditions. Its products include Evo Cortical, Evo sEEG, and OneRF. The company was founded by Mark Christianson on August 20, 2009 and is headquartered in Eden Prairie, MN.
NMTC At a Glance
NeuroOne Medical Technologies Corp.
7599 Anagram Drive
Eden Prairie, Minnesota 55344
| Phone | 1-952-426-1383 | Revenue | 12.10M | |
| Industry | Medical Specialties | Net Income | -3,605,374.00 | |
| Sector | Health Technology | 2025 Sales Growth | 250.353% | |
| Fiscal Year-end | 09 / 2026 | Employees | 18 | |
| View SEC Filings |
NMTC Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 2.949 |
| Price to Book Ratio | 6.283 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -7.409 |
| Enterprise Value to Sales | 2.428 |
| Total Debt to Enterprise Value | 0.009 |
NMTC Efficiency
| Revenue/Employee | 672,094.00 |
| Income Per Employee | -200,298.556 |
| Receivables Turnover | 9.565 |
| Total Asset Turnover | 1.489 |
NMTC Liquidity
| Current Ratio | 4.43 |
| Quick Ratio | 3.463 |
| Cash Ratio | 2.853 |
NMTC Profitability
| Gross Margin | 67.297 |
| Operating Margin | -34.936 |
| Pretax Margin | -29.802 |
| Net Margin | -29.802 |
| Return on Assets | -44.38 |
| Return on Equity | -91.338 |
| Return on Total Capital | -49.124 |
| Return on Invested Capital | -87.593 |
NMTC Capital Structure
| Total Debt to Total Equity | 3.772 |
| Total Debt to Total Capital | 3.635 |
| Total Debt to Total Assets | 2.453 |
| Long-Term Debt to Equity | 2.024 |
| Long-Term Debt to Total Capital | 1.95 |